ClinicalTrials.Veeva

Menu

In-vivo Extraction of Pb, Cd andTSNA From Swedish Snus (SMWS03)

C

Contract Research Organization el AB

Status and phase

Completed
Phase 1

Conditions

Smokeless Tobacco
Harm Reduction
Smoking Cessation

Treatments

Procedure: Buccal Administration of nicotine

Study type

Interventional

Funder types

Industry

Identifiers

NCT01249339
2004/3/2

Details and patient eligibility

About

In an open label, randomized, two-way cross-over study, 32 male healthy regular snus users will be given repeated doses of four different types of portion snus: "General", "Catch", "Catch Mini" and "Catch Dry Mini". Each portion of used snus will be collected and frozen (-20 oC) pending analysis of lead (Pb), cadmium (Cd), nicotine and tobacco specific nitrosamines (TSNAs). Unused snus is collected and deep frozen for analysis and calculation of extracted dose. Calculations of extracted amount of lead, cadmium, nicotine and tobacco specific nitrosamines (TSNAs) respectively, will be done for each type of snus.

Full description

Comparisons:

A= "General Portion" 1 g portion snus containing approximately 8 mg nicotine per portion.

B= "Catch Licorice Portion" 1 g portion snus containing approximately 8 mg nicotine per portion.

C= "Catch Licorice Portion Mini" 0.5 g portion snus containing approximately 4 mg nicotine per portion.

D= "Catch Dry Licorice Portion Mini" 0.3 g portion snus containing approximately 4 mg nicotine per portion.

Swedish portion snus will be administered once every hour (4 administrations/brand) and will be kept between the upper lip and the gum for 30 minutes. Preload of own brand each morning.

Enrollment

32 patients

Sex

Male

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Non-smokers, 18 to 50 years of age.
  • Habitual use of > 7 portions snus daily since minimum 1 year.
  • Healthy according to the health declaration and interview.
  • Written informed consent given.

Exclusion criteria

  • Concurrent participation in another clinical trial.
  • History of allergy.
  • History of allergy.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

32 participants in 4 patient groups

General 1 g pouch
Active Comparator group
Description:
Oral pouch 0.3-1g, single dose. One pouch administered over 30 minutes.
Treatment:
Procedure: Buccal Administration of nicotine
Procedure: Buccal Administration of nicotine
Procedure: Buccal Administration of nicotine
Procedure: Buccal Administration of nicotine
Catch Licoice 1 g pouch
Active Comparator group
Description:
Oral pouch 1g, single dose. One pouch administered over 30 minutes.
Treatment:
Procedure: Buccal Administration of nicotine
Procedure: Buccal Administration of nicotine
Procedure: Buccal Administration of nicotine
Procedure: Buccal Administration of nicotine
Catch Licorice Mini 0.5 g pouch
Active Comparator group
Description:
Oral pouch 0.5g, single dose. One pouch administered over 30 minutes.
Treatment:
Procedure: Buccal Administration of nicotine
Procedure: Buccal Administration of nicotine
Procedure: Buccal Administration of nicotine
Procedure: Buccal Administration of nicotine
Catch Licorice dry mini 0.3 g pouch
Active Comparator group
Description:
Oral pouch 0.3 g, single dose. One pouch administered over 30 minutes.
Treatment:
Procedure: Buccal Administration of nicotine
Procedure: Buccal Administration of nicotine
Procedure: Buccal Administration of nicotine
Procedure: Buccal Administration of nicotine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems